These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3481271)

  • 1. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.
    Nara PL; Hatch WC; Dunlop NM; Robey WG; Arthur LO; Gonda MA; Fischinger PJ
    AIDS Res Hum Retroviruses; 1987; 3(3):283-302. PubMed ID: 3481271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid, automated microtiter assay for measuring neutralization of HIV-1.
    Laal S; Burda S; Sharpe S; Zolla-Pazner S
    AIDS Res Hum Retroviruses; 1993 Aug; 9(8):781-5. PubMed ID: 8217345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
    Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
    AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.
    Nara PL; Robey WG; Gonda MA; Carter SG; Fischinger PJ
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3797-801. PubMed ID: 3473484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium-inducing capacity of human immunodeficiency virus (HIV): analysis by the use of cloned viruses.
    el-Farrash MA; Harada S
    Microbiol Immunol; 1989; 33(7):549-59. PubMed ID: 2505024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    Yoshiyama H; Nakashima H; Kobayashi S; Yamamoto N
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):91-8. PubMed ID: 3284555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays.
    McKeating JA; McKnight A; McIntosh K; Clapham PR; Mulder C; Weiss RA
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3327-33. PubMed ID: 2575137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein.
    Goudsmit J; Smit L; Klaver B; Asher DM; Wolff A; Gibbs CJ; Gajdusek DC
    Viral Immunol; 1987-1988; 1(3):225-40. PubMed ID: 3509947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable and conserved neutralization antigens of human immunodeficiency virus.
    Weiss RA; Clapham PR; Weber JN; Dalgleish AG; Lasky LA; Berman PW
    Nature; 1986 Dec 11-17; 324(6097):572-5. PubMed ID: 2431324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a flow cytometric assay for the detection and measurement of neutralizing antibodies against human immunodeficiency virus.
    Folghera S; Fiorentini S; Martinelli F; Ravizzola G; Gargiulo F; Terlenghi L; De Francesco M; Caruso A; Turano A
    New Microbiol; 1994 Jan; 17(1):21-8. PubMed ID: 8127226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.
    Nichols CN; Bernal I; Prince AM; Andrus L
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):49-56. PubMed ID: 11804556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.
    Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
    Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
    J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
    Goudsmit J; Thiriart C; Smit L; Bruck C; Gibbs CJ
    Vaccine; 1988 Jun; 6(3):229-32. PubMed ID: 3166553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection and expression of an infectious proviral clone and subgenomic envelope construct of a human immunodeficiency virus.
    Boyd AL; Wood TG; Buckley A; Fischinger PJ; Gilden RV; Gonda MA
    AIDS Res Hum Retroviruses; 1988 Feb; 4(1):31-41. PubMed ID: 2835071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.